Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease
1996

Collagenase and Tissue Inhibitor Expression in Pancreatic Cancer

Sample size: 50 publication Evidence: high

Author Information

Author(s): SR Bramhall, GWH Stamp, J Dunn, NR Lemoine, JP Neoptolemos

Primary Institution: City Hospital NHS Trust Birmingham; ICRF Oncology Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London; University of Birmingham; Queen Elizabeth Hospital, Birmingham, UK.

Hypothesis

The study investigates the expression of metalloproteinases and their inhibitors in pancreatic and ampullary cancers.

Conclusion

The study found that MMP2, MMP3, and TIMP1 are significantly expressed in pancreatic and ampullary cancers, suggesting their role in tumor invasion and metastasis.

Supporting Evidence

  • The abundance of MMP2, MMP3, and TIMP1 was greater in pancreatic and ampullary cancer than in other pathologies.
  • Immunoreactivity in malignant epithelial cells was significantly higher than in stromal tissues.
  • Strong correlations were found between the immunoreactivity of MMP2 and TIMP1.

Takeaway

This study looked at how certain proteins related to cancer are found in patients with pancreatic and ampullary cancers, showing that these proteins might help the cancer spread.

Methodology

Immunohistochemistry was performed on tissue sections from 50 patients to assess the expression of MMP2, MMP3, and TIMP1.

Participant Demographics

Patients included 27 with pancreatic cancer, 12 with ampullary cancer, 3 with low bile duct cancer, 3 with neuroendocrine tumors, and 5 with chronic pancreatitis.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication